{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:35:48Z","timestamp":1787841348132,"version":"build-2784847793"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,4]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Plasma cell leukemia (PCL) is a rare but aggressive subtype of plasma cell dyscrasia. It is known to present with highly variable morphological features and may mimic with other lymphoid neoplasms. Multicolor flow cytometry (MFC) with availability of newer markers is highly useful in the diagnosis of the plasma cell leukemia. We present an immunophenotypic profile in ten cases of PCL along with their clinical and laboratory findings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>We retrospectively studied immunophenotypic profile of 10 cases of plasma cell leukemia (out of 4615 cases of hematolymphoid neoplasms) using five parameter, three color flow cytometric analysis. We also studied their clinical presentation and other laboratory findings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Common clinical features at presentation were weakness, bone pain, anemia, thrombocytopenia and osteolytic lesions. Plasma cell population was identified on strong expression of CD38 and co-expression of CD38 and CD138. CD56 was expressed in 44% cases. CD19 and CD20 were negative in all cases. Surface light chain restriction was seen in 50% cases and in remaining 50% cases revealed cytoplasmic light chain restriction. CD117 was expressed in one out of two cases studied.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>MFC immunophenotyping is highly useful to differentiate Plasma cell leukemia from other chronic lymphoproliferative disorders with plasmacytoid morphology as well as from non-neoplastic reactive PC and co-expression of CD38 and CD138 is a best combination to identify the plasma cells by MFC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/0377-4929.81603","type":"journal-article","created":{"date-parts":[[2011,5,28]],"date-time":"2011-05-28T10:08:01Z","timestamp":1306577281000},"page":"294-298","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Immunophenotypic profile of plasma cell leukemia: A retrospective study in a reference cancer center in India and review of literature"],"prefix":"10.4103","volume":"54","author":[{"given":"Prashant R.","family":"Tembhare","sequence":"first","affiliation":[{"name":"Department of Pathology, Hematopathology Laboratory, Tata Memorial Center, Mumbai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. G.","family":"Subramanian","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hematopathology Laboratory, Tata Memorial Center, Mumbai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunal","family":"Sehgal","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hematopathology Laboratory, Tata Memorial Center, Mumbai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Badrinath","family":"Yajamanam","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hematopathology Laboratory, Tata Memorial Center, Mumbai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hematopathology Laboratory, Tata Memorial Center, Mumbai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijaya","family":"Gadge","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hematopathology Laboratory, Tata Memorial Center, Mumbai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Inamdar","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Tata Memorial Center, Mumbai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumeet","family":"Gujral","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hematopathology Laboratory, Tata Memorial Center, Mumbai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250922","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1182\/blood.V97.3.822","article-title":"Cytogenetic, interphase, and multicolor fluorescence in situ hybridization analyses in primary plasma cell leukemia: A study of 40 patients at diagnosis, on behalf of the Intergroupe Francophone du Myelome and the Groupe Francais de Cytogenetique Hematologique","volume":"97","author":"Avet-Loiseau","year":"2001","journal-title":"Blood"},{"key":"R2-20250922","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/jjco\/hym037","article-title":"Combination chemotherapy with bortezomib, cyclophosphamide and dexamethasone may be effective for plasma cell leukemia","volume":"37","author":"Kim","year":"2007","journal-title":"Jpn J Clin Oncol"},{"key":"R3-20250922","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/(SICI)1097-0320(19981215)34:6<264::AID-CYTO4>3.0.CO;2-P","article-title":"Comparison between a lyse-and-then-wash method and a lyse-non-wash techn0ique for the enumeration of CD34+ hematopoietic progenitor cells","volume":"34","author":"Men\u00e9ndez","year":"1998","journal-title":"Cytometry"},{"key":"R4-20250922","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/cyto.990120612","article-title":"Membrane cell permeabilization with saponin and multiparametric analysis by flow cytometry","volume":"12","author":"Jacob","year":"1991","journal-title":"Cytometry"},{"key":"R5-20250922","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/1097-0142(19890301)63:5<859::AID-CNCR2820630511>3.0.CO;2-B","article-title":"Immunophenotypic spectrum of plasma cell leukemia","volume":"63","author":"Linden","year":"1989","journal-title":"Cancer"},{"key":"R6-20250922","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/ajh.2830390302","article-title":"Immunophenotype and DNA content of myeloma cells in primary plasma cell leukemia","volume":"39","author":"Shimazaki","year":"1992","journal-title":"Am J Hematol"},{"key":"R7-20250922","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0145-2126(00)00102-8","article-title":"Primary plasma cell leukaemia: a report of 18 cases","volume":"25","author":"Costello","year":"2001","journal-title":"Leuk Res"},{"key":"R8-20250922","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.anndiagpath.2005.12.011","article-title":"Primary plasma cell leukemia: morphologic, immunophenotypic, and cytogenetic features of 4 cases treated with chemotherapy and stem cell transplantation","volume":"10","author":"Johnson","year":"2006","journal-title":"Ann Diagn Pathol"},{"key":"R9-20250922","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1046\/j.1365-2141.1997.72653.x","article-title":"Circulating plasma cells in multiple myeloma: characterization and correlation with disease stage","volume":"97","author":"Rawstron","year":"1997","journal-title":"Br J Haematol"},{"key":"R10-20250922","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s12032-007-9011-5","article-title":"Thirty patients with primary plasma cell leukemia: a single center experience","volume":"25","author":"Colovic","year":"2008","journal-title":"Med Oncol"},{"key":"R11-20250922","first-page":"419","article-title":"Plasma cell leukaemia mimicking acute monocytic leukaemia in the course of multiple myeloma","volume":"35","author":"Eclache","year":"1993","journal-title":"Nouv Rev Fr Hematol"},{"key":"R12-20250922","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1093\/jjco\/hyg043","article-title":"A case of primary plasma cell leukemia with hairy-cell morphology and lambda-type Bence-Jones protein immunohistochemical and molecular analysis","volume":"33","author":"Tanioka","year":"2003","journal-title":"Jpn J Clin Oncol"},{"key":"R13-20250922","first-page":"221","article-title":"Plasma cell leukemia masquerading as ALL-L3\u2013a case report","volume":"48","author":"Tripathy","year":"2005","journal-title":"Indian J Pathol Microbiol"},{"key":"R14-20250922","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000207385","article-title":"Plasma cell leukaemia. Diagnostic problems in our experience with 11 cases","volume":"63","author":"Toma","year":"1980","journal-title":"Acta Haematol"},{"key":"R15-20250922","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1182\/blood.V88.5.1780.1780","article-title":"Peripheral blood monoclonal plasma cells as a predictor of survival in patients with multiple myeloma","volume":"88","author":"Witzig","year":"1996","journal-title":"Blood"},{"key":"R16-20250922","first-page":"392","article-title":"Immunophenotypic approach to the identification and characterization of clonal plasma cells from patients with monoclonal gammopathies","volume":"18","author":"P\u00e9rez-Andr\u00e9s","year":"2004","journal-title":"J Biol Regul Homeost Agents"},{"key":"R17-20250922","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1309\/74R4TB90BUWH27JX","article-title":"Flow cytometric immunophenotypic analysis of 306 cases of multiple myeloma","volume":"121","author":"Lin","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"R18-20250922","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3324\/haematol.11080","article-title":"Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders","volume":"93","author":"Rawstron","year":"2008","journal-title":"Haematologica"},{"key":"R19-20250922","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1182\/blood.V81.10.2658.2658","article-title":"Phenotypic difference of normal plasma cells from mature myeloma cells","volume":"81","author":"Harada","year":"1993","journal-title":"Blood"},{"key":"R20-20250922","first-page":"1165","article-title":"Differential diagnosis of malignant lymphomas and related disorders by specific pattern of expression of immunophenotypic markers revealed by multiparameter flow cytometry (Review)","volume":"17","author":"Weisberger","year":"2000","journal-title":"Int J Oncol"},{"key":"R21-20250922","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1046\/j.1365-2141.1999.01685.x","article-title":"High-sensitive immunophenotyping and DNA ploidy studies for the investigation of minimal residual disease in multiple myeloma","volume":"107","author":"Almeida","year":"1999","journal-title":"Br J Haematol"},{"key":"R22-20250922","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3109\/10428199809057596","article-title":"Syndecan-1 expression on malignant cells from the blood and marrow of patients with plasma cell proliferative disorders and B-cell chronic lymphocytic leukemia","volume":"31","author":"Witzig","year":"1998","journal-title":"Leuk Lymphoma"},{"key":"R23-20250922","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1182\/blood.V93.3.1032","article-title":"Primary plasma cell leukemia: clinical, immunophenotypic, DNA ploidy, and cytogenetic characteristics","volume":"93","author":"Garcia-Sanz","year":"1999","journal-title":"Blood"},{"key":"R24-20250922","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1038\/sj.leu.2401211","article-title":"The absence of CD56 (NCAM) on malignant plasma cells is a hallmark of plasma cell leukemia and of a special subset of multiple myeloma","volume":"12","author":"Pellat-Deceunynck","year":"1998","journal-title":"Leukemia"},{"key":"R25-20250922","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1365-2141.1996.tb08993.x","article-title":"Expression of the CD117 antigen (c-Kit) on normal and myelomatous plasma cells","volume":"95","author":"Ocqueteau","year":"1996","journal-title":"Br J Haematol"},{"key":"R26-20250922","first-page":"951","article-title":"Expression of CD117 antigen on multiple myeloma and its significance","volume":"23","author":"Li","year":"2004","journal-title":"Ai Zheng"}],"container-title":["Indian Journal of Pathology and Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00004270-201154020-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:50:36Z","timestamp":1787838636000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004270-201154020-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.4103\/0377-4929.81603","relation":{},"ISSN":["0377-4929","0974-5130"],"issn-type":[{"value":"0377-4929","type":"print"},{"value":"0974-5130","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}